Major players like Thermo Fisher Scientific, Bio-Rad, QIAGEN, and Merck are expanding their multiplex immunoassay platforms to meet growing clinical and research needs. https://finance.yahoo.com/news/multi-plex-immunoassays-market-reach-140100900.html